Journey Medical (DERM) Net Margin: 2020-2025
Historic Net Margin for Journey Medical (DERM) over the last 5 years, with Sep 2025 value amounting to -13.13%.
- Journey Medical's Net Margin rose 321.00% to -13.13% in Q3 2025 from the same period last year, while for Sep 2025 it was -14.38%, marking a year-over-year increase of 1736.00%. This contributed to the annual value of -26.14% for FY2024, which is 2127.00% down from last year.
- Per Journey Medical's latest filing, its Net Margin stood at -13.13% for Q3 2025, which was up 47.25% from -24.89% recorded in Q2 2025.
- Journey Medical's Net Margin's 5-year high stood at 48.61% during Q3 2023, with a 5-year trough of -124.17% in Q4 2021.
- In the last 3 years, Journey Medical's Net Margin had a median value of -22.63% in 2024 and averaged -24.88%.
- In the last 5 years, Journey Medical's Net Margin slumped by 14,031bps in 2021 and then surged by 11,116bps in 2023.
- Over the past 5 years, Journey Medical's Net Margin (Quarterly) stood at -124.17% in 2021, then soared by 5,752bps to -66.65% in 2022, then skyrocketed by 5,261bps to -14.05% in 2023, then skyrocketed by 2,566bps to 11.62% in 2024, then surged by 321bps to -13.13% in 2025.
- Its Net Margin was -13.13% in Q3 2025, compared to -24.89% in Q2 2025 and -31.00% in Q1 2025.